Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitemnemosynepharma.com
CategoryBioTech
Phone401.632.0383
Emailinfo@mnemosynepha...
Employees
Founded2010

Offices

Providence, USA
One Davol Square
Suite 200
Providence, RI, 02903
USA

People

CEO
Chief Scientific Officer

Funding

TOTAL $11.4M
FUNDING TOTAL $11.4M
Series A, 2/2012
Access BridgeGap Ventures
Slater Technology Fund
$5.4M
Series A, 6/2013
Atlas Venture
Clal Biotechnology
$6M

Tags

Mnemosyne Pharmaceuticals

Mnemosyne Pharmaceuticals, Inc. is developing an innovative drug discovery platform that will address medical needs in several segments of the mental health market.

Mnemosyne was founded in 2010 with seed funding from Slater Technology Fund and private investors. Recently, Mnemosyne closed on a Series A round totaling $5.4M. Mnemosyne is using these funds to develop a new class of small molecule drugs that modulate the activity of different subtypes of the NMDA receptor.

Recent Milestones

Videos

Screenshots

Mnemosyne Pharmaceuticals screenshot
Above: Home Page
Uploaded: 2/17/12

Sources

  1. Mnemosyne Pharmaceuticals lands $5.4M in Series A round (masshightech.com) [edit]
  2. Mnemosyne closes on additional $6M in Series A funding (pbn.com) [edit]
Edit This Page
Last Edited 11/28/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy